All Type of News
Why did FTC investigate pharmas A,B, D & L?
The Fair Trade Commission(FTC) reportedly investigated a Korean pharma B and a multinational pharma L last week and a Korean pharma D and a multinational pharma A on the 18th.
The investigation was about ‘pay-for-del...
Samsung Bioepis submits biologic application of Herceptin biosimilar in U.S.
Samsung Bioepis(CEO/President Han-Seung Ko) is getting ready to target the U.S. market followed by the European one with ‘SB3(generic name: trastuzumab, European name: ontruzant),’ a biosimilar for the treatment of br...
Daewoong & Samsung Bioepis’ exclusive sales agreement of Samfenet in Korea
Daewoong Pharmaceutical will jump into the ‘anticancer drug field.’
Daewoong Pharmaceutical announced the company signed an exclusive sales agreement of ‘Samfenet,’ an anticancer biosimilar, in Korea with Samsung Bio...
KPBMA establishes private-public AI Novel Drug Development Support Center by 2019
The ‘Artificial Intelligence(AI) Novel Drug Development Support Center’ jointed established by private and public organizations will be launched in 2019 in Korea, which attract attention of the pharmaceutical industry...
Korean pharmas’ intensified reliability only on developing generic medicines
When it comes to the generic drug development, Korean pharmaceutical companies were analyzed to focus only on medicines with expired patents. This year, there were 625 medicines recognized by bioequivalent test, which...
Which recorded the highest full-time employee rate among top 20 sales pharmas?
While pharmaceutical companies have actively responded to the government’s policy to address the Moon Jae-In Administration’s key issue, Hanmi Pharm was reportedly a pharmaceutical company with the largest number of e...
Innovative pharmas superior in R&D investment percentage to sales compared to listed pharmas and drug manufacturers
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Hee-Mok Won) published, distributed and revealed the ‘2017 Pharmaceutical Industry Data Book,’ which a reader can see the pharmaceutical indus...
MFDS, “Chaos over generics have caused CSOs’ illegal operation”
“Generics have encouraged pharmaceutical companies to use illegal rebates and also made CSOs run their business illegally.”
The Ministry of Food and Drug Safety(MFDS) were reportedly sharing generic medicine problems...
Celltrion’s Herzuma receives ‘recommendation for approval’ from European CHMP
On the 15th(local time), Celltrion announced to acquire ‘recommendation for approval’ on all the indications for ‘Herzuma(generic name: trastuzumab, development name: CT-P6),’ an antibody biosimilar for the treatment ...
Pharmaceutical distribution industry worrying about securing supply from multinational pharmas with long vacation
Pharmaceutical distribution companies have started to worry about securing supply of products sold by pharmaceutical companies, like multinational pharmaceutical companies, which will take a long vacation during the u...
